1. Home
  2. FTCI vs TLSA Comparison

FTCI vs TLSA Comparison

Compare FTCI & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FTC Solar Inc.

FTCI

FTC Solar Inc.

HOLD

Current Price

$2.20

Market Cap

122.4M

Sector

Technology

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.08

Market Cap

124.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTCI
TLSA
Founded
2017
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
122.4M
124.0M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
FTCI
TLSA
Price
$2.20
$1.08
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$10.80
N/A
AVG Volume (30 Days)
230.3K
832.9K
Earning Date
05-01-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$99,687,000.00
N/A
Revenue This Year
$65.44
N/A
Revenue Next Year
$45.97
N/A
P/E Ratio
N/A
N/A
Revenue Growth
110.51
N/A
52 Week Low
$2.28
$0.87
52 Week High
$12.75
$2.35

Technical Indicators

Market Signals
Indicator
FTCI
TLSA
Relative Strength Index (RSI) 29.04 58.03
Support Level N/A $1.14
Resistance Level $5.40 $1.15
Average True Range (ATR) 0.29 0.10
MACD 0.01 0.03
Stochastic Oscillator 0.00 81.98

Price Performance

Historical Comparison
FTCI
TLSA

About FTCI FTC Solar Inc.

FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Share on Social Networks: